ClinicalTrials.Veeva

Menu

Early Recovery After Cesarean Delivery - Maternal Glucose Homeostasis Following Preoperative Glucose Dose

W

Women's Hospital HUS

Status

Not yet enrolling

Conditions

Cesarean Section Complications
Gestational Diabetes

Treatments

Dietary Supplement: Oral glucose in liquid form

Study type

Observational

Funder types

Other

Identifiers

NCT05396378
Tutkimussuunnitelma_250322_III

Details and patient eligibility

About

Diabetic parturients planned for cesarean delivery will be recruited for the study. They will receive a fixed glucose dose to mimize the effects of fasting preoperatively and their blood glucose levels will be monitored.

Full description

Informed voluntary parturients planned for cesarean delivery will be informed about the study. The parturients will get prepacked glucose drink containing 100 g and 50 g glucose, respectively. They will consume the 100 g of glucose the night before the planned operation and the 50 g on the morning of the planned cesarean delivery. Their blood glucose level will be monitored by percutaneous continuous blood glucose monitoring every 30 minutes for 2 hours following the glucose dose in the evening and for four hours in the morning of the operation.

The subjective well being of these parturients will be also qualitatively assessed.

Enrollment

150 estimated patients

Sex

Female

Ages

18 to 55 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Volunteers to participate in the study
  • Diabetes, either gestational or type II
  • Planned for cesarean delivery

Exclusion criteria

  • Type I diabetes

Trial design

150 participants in 2 patient groups

Gestational diabetes
Description:
Any parturient who after information agrees to participate in the study. The treatment of the gestational diabetes may be by diet, metformin or insulin according to the hospital's normal protocol.
Treatment:
Dietary Supplement: Oral glucose in liquid form
Type II diabetes
Description:
Any parturient who after information agrees to participate in the study. The treatment of the diabetes may be by diet, metformin or insulin according to the hospital's normal protocol.
Treatment:
Dietary Supplement: Oral glucose in liquid form

Trial contacts and locations

1

Loading...

Central trial contact

Marja Kaijomaa, MD PhD; Antti Vaananen, MD PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems